HRT Financial LP cuts NewGenIvf Group (NIVF) stake with share sale

Rhea-AI Filing Summary

HRT Financial LP, a ten percent owner of NewGenIvf Group Ltd, reported an open-market sale of 85,317 shares of Common Stock at $0.80 per share on May 27, 2026. After this transaction, HRT Financial LP directly holds 54,561 shares of NewGenIvf Common Stock.

Insider Trade Summary

Net Seller: 85,317 shares ($68,254)

Net Sell 1 txn

Insider HRT FINANCIAL LP

Role null

Sold 85,317 shs ($68K)

Type	Security	Shares	Price	Value
Sale	Common Stock	85,317	$0.80	$68K

Holdings After Transaction: Common Stock — 54,561 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 85,317 shares Sale price: $0.80 per share Shares held after sale: 54,561 shares +1 more

4 metrics

Shares sold 85,317 shares Open-market sale of NewGenIvf Common Stock on May 27, 2026

Sale price $0.80 per share Price for the 85,317-share open-market sale

Shares held after sale 54,561 shares Direct ownership of NewGenIvf Common Stock following transaction

Net share change -85,317 shares Net-sell direction in transaction summary for this Form 4

Key Terms

open-market sale, ten percent owner, Common Stock, Form 4

4 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

ten percent owner regulatory

""is_ten_percent_owner": 1"

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HRT FINANCIAL LP

(Last) (First) (Middle)

3 WORLD TRADE CENTER, 175 GREENWICH STRE

76TH FLOOR

(Street)

NEW YORK NEW YORK 10007

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/27/2026		S		85,317	D	$0.8	54,561	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Adam Nunes	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HRT Financial LP report for NIVF?

HRT Financial LP reported an open-market sale of 85,317 shares of NewGenIvf Group Ltd Common Stock. The shares were sold at a price of $0.80 per share in a single non-derivative transaction dated May 27, 2026.

At what price were NewGenIvf (NIVF) shares sold by HRT Financial LP?

The reported sale of NewGenIvf Group Ltd Common Stock by HRT Financial LP was executed at $0.80 per share. This price applies to the entire 85,317-share open-market transaction disclosed in the Form 4 filing.

How many NewGenIvf (NIVF) shares does HRT Financial LP hold after the sale?

Following the reported sale, HRT Financial LP directly holds 54,561 shares of NewGenIvf Group Ltd Common Stock. This post-transaction balance reflects the remaining position after disposing of 85,317 shares in the open market.

What type of transaction did HRT Financial LP execute in NewGenIvf (NIVF) stock?

HRT Financial LP executed an open-market sale of NewGenIvf Group Ltd Common Stock. The Form 4 describes the transaction with code “S,” indicating a sale in the open market or a private transaction of 85,317 non-derivative shares.

Is HRT Financial LP considered a major shareholder of NewGenIvf (NIVF)?

Yes, HRT Financial LP is identified as a ten percent owner of NewGenIvf Group Ltd. This status means it holds, or has held, a significant ownership stake that triggers ongoing insider reporting obligations under Section 16 rules.